127 related articles for article (PubMed ID: 26716385)
1. Downregulation of TRAP1 sensitizes glioblastoma cells to temozolomide chemotherapy through regulating metabolic reprogramming.
Wu J; Liu Y; Cho K; Dong X; Teng L; Han D; Liu H; Chen X; Chen X; Hou X; Peng F; Bi Y; Shen C; Zhao S
Neuroreport; 2016 Feb; 27(3):136-44. PubMed ID: 26716385
[TBL] [Abstract][Full Text] [Related]
2. STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?
Villalva C; Martin-Lannerée S; Cortes U; Dkhissi F; Wager M; Le Corf A; Tourani JM; Dusanter-Fourt I; Turhan AG; Karayan-Tapon L
Int J Cancer; 2011 Feb; 128(4):826-38. PubMed ID: 20473906
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells.
D'Alimonte I; Nargi E; Zuccarini M; Lanuti P; Di Iorio P; Giuliani P; Ricci-Vitiani L; Pallini R; Caciagli F; Ciccarelli R
Purinergic Signal; 2015 Sep; 11(3):331-46. PubMed ID: 25976165
[TBL] [Abstract][Full Text] [Related]
4. Heat Shock Factor 1 Depletion Sensitizes A172 Glioblastoma Cells to Temozolomide via Suppression of Cancer Stem Cell-Like Properties.
Im CN; Yun HH; Lee JH
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241425
[TBL] [Abstract][Full Text] [Related]
5. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
6. Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth.
Olmez I; Shen W; McDonald H; Ozpolat B
J Cell Mol Med; 2015 Jun; 19(6):1262-72. PubMed ID: 25787115
[TBL] [Abstract][Full Text] [Related]
7. MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells.
Joshi K; Banasavadi-Siddegowda Y; Mo X; Kim SH; Mao P; Kig C; Nardini D; Sobol RW; Chow LM; Kornblum HI; Waclaw R; Beullens M; Nakano I
Stem Cells; 2013 Jun; 31(6):1051-63. PubMed ID: 23404835
[TBL] [Abstract][Full Text] [Related]
8. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway.
Riganti C; Salaroglio IC; Caldera V; Campia I; Kopecka J; Mellai M; Annovazzi L; Bosia A; Ghigo D; Schiffer D
Neuro Oncol; 2013 Nov; 15(11):1502-17. PubMed ID: 23897632
[TBL] [Abstract][Full Text] [Related]
10. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
Montaldi AP; Godoy PR; Sakamoto-Hojo ET
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
[TBL] [Abstract][Full Text] [Related]
11. HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells.
Colamaio M; Tosti N; Puca F; Mari A; Gattordo R; Kuzay Y; Federico A; Pepe A; Sarnataro D; Ragozzino E; Raia M; Hirata H; Gemei M; Mimori K; Del Vecchio L; Battista S; Fusco A
Expert Opin Ther Targets; 2016 Oct; 20(10):1169-79. PubMed ID: 27486901
[TBL] [Abstract][Full Text] [Related]
12. Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide.
Yan T; Skaftnesmo KO; Leiss L; Sleire L; Wang J; Li X; Enger PØ
BMC Cancer; 2011 Dec; 11():524. PubMed ID: 22185371
[TBL] [Abstract][Full Text] [Related]
13. Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma.
Chang KY; Huang CT; Hsu TI; Hsu CC; Liu JJ; Chuang CK; Hung JJ; Chang WC; Tsai KK; Chuang JY
Biochem Biophys Res Commun; 2017 Nov; 493(1):14-19. PubMed ID: 28939040
[TBL] [Abstract][Full Text] [Related]
14. JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression.
Okada M; Sato A; Shibuya K; Watanabe E; Seino S; Suzuki S; Seino M; Narita Y; Shibui S; Kayama T; Kitanaka C
Int J Oncol; 2014 Feb; 44(2):591-9. PubMed ID: 24316756
[TBL] [Abstract][Full Text] [Related]
15. Suppressing H19 Modulates Tumorigenicity and Stemness in U251 and U87MG Glioma Cells.
Li W; Jiang P; Sun X; Xu S; Ma X; Zhan R
Cell Mol Neurobiol; 2016 Nov; 36(8):1219-1227. PubMed ID: 26983719
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway.
Wu J; Ji Z; Liu H; Liu Y; Han D; Shi C; Shi C; Wang C; Yang G; Chen X; Shen C; Li H; Bi Y; Zhang D; Zhao S
Toxicol Lett; 2013 Jun; 220(1):61-9. PubMed ID: 23542114
[TBL] [Abstract][Full Text] [Related]
17. TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells.
Tian T; Li A; Lu H; Luo R; Zhang M; Li Z
Biochem Biophys Res Commun; 2015 Aug; 463(4):638-43. PubMed ID: 26043698
[TBL] [Abstract][Full Text] [Related]
18. Interplay between TRAP1 and Sirtuin-3 Modulates Mitochondrial Respiration and Oxidative Stress to Maintain Stemness of Glioma Stem Cells.
Park HK; Hong JH; Oh YT; Kim SS; Yin J; Lee AJ; Chae YC; Kim JH; Park SH; Park CK; Park MJ; Park JB; Kang BH
Cancer Res; 2019 Apr; 79(7):1369-1382. PubMed ID: 30683653
[TBL] [Abstract][Full Text] [Related]
19. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
Bielecka-Wajdman AM; Lesiak M; Ludyga T; Sieroń A; Obuchowicz E
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1249-1256. PubMed ID: 28500556
[TBL] [Abstract][Full Text] [Related]
20. EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide.
Cominelli M; Grisanti S; Mazzoleni S; Branca C; Buttolo L; Furlan D; Liserre B; Bonetti MF; Medicina D; Pellegrini V; Buglione M; Liserre R; Pellegatta S; Finocchiaro G; Dalerba P; Facchetti F; Pizzi M; Galli R; Poliani PL
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25739547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
